Trial intelligence / Profile preview

COPE-HCV: Continuous Intron A Delivery via Pump for Chronic HCV

NCT00919633Phase 2Completed

Sponsor
Medtronic
Start
Jun 2009
Primary completion
Jul 2012
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of interferon alfa in hepatitis C (HCV), sponsored by Medtronic. Started Jun 2009; status: completed.

02

Drugs

interferon alfa
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00919633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00919633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call